Abbreviations:
TB (Tuberculosis), NTM (non-tuberculous, mycobacteria), NTM-LD (non-tuberculous, mycobacteria, lung, disease), PET/FDG, RGM (rapidly, growing, mycobacteria), SGM (slowly, growing, mycobacteria), SUV (standardized, uptake, value), CF (cystic, fibrosis)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of InfectionReferences
- Seventy years of evidence on the efficacy and safety of drugs for treating leprosy: a network meta-analysis.J Infect. 2023 Feb 14; S0163-4453 (00087-00087) (Epub ahead of print)https://doi.org/10.1016/j.jinf.2023.02.019
- Non-tuberculous mycobacterial pulmonary disease.Eur Respir J. 2019; 54: 1900250https://doi.org/10.1183/13993003.00250-2019
Daley C.L. , Iaccarino J.M. , Lange C. , et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis 2020 ;71(4):e1-e36. doi:10.1093/cid/ciaa241
- Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK.BMJ Open Respir Res. 2020; 7e000591https://doi.org/10.1136/bmjresp-2020-000591
- An update on the role of 18F-FDG-PET/CT in major infectious and inflammatory diseases.Am J Nucl Med Mol Imaging. 2019 Dec 15; 9 (19): 255-273
- Chiaravalloti A. Usefulness of FDG PET/CT in the management of tuberculosis. 14. PLOS ONE, 2019e0221516https://doi.org/10.1371/journal.pone.0221516
- IRENE Network. The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.Multidiscip Respir Med. 2018 Aug 9; 13: 33https://doi.org/10.1186/s40248-018-0141-8
Del Giudice G. , Bianco A. , Cennamo A. , et al. Lung and Nodal Involvement in Nontuberculous Mycobacterial Disease: PET/CT Role. BioMed Res Int. 2015 ;2015:1-8. doi:10.1155/2015/353202
- Usefulness of 18F-fluorodeoxyglucose positron emissiontomography for diagnosing disease activity and monitoring therapeutic response in patients withpulmonary mycobacteriosis.Eur J Nucl Med Mol Imaging. 2009; 36: 632-639https://doi.org/10.1007/s00259-008-1009-5
- Differentiating nontuberculous mycobacterium pulmonary disease from pulmonary tuberculosis through the analysis of the cavity features in CT images using radiomics.BMC Pulm Med. 2022 Jan 7; 22: 4https://doi.org/10.1186/s12890-021-01766-2